Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Yawalkar

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of the American Academy of Dermatology|December 1, 1991
A double-blind, multicenter trial of 0.05% halobetasol propionate ointment and 0.05% clobetasol 17-propionate ointment in the treatment of patients with chronic, localized atopic dermatitis or lichen simplex chronicusB Datz, S Yawalkar
Journal of the American Academy of Dermatology|December 1, 1991
A comparative, multicenter, double blind trial of 0.05% halobetasol propionate ointment and 0.1% betamethasone valerate ointment in the treatment of patients with chronic, localized plaque psoriasisG Blum, S Yawalkar
Journal of the American Academy of Dermatology|December 1, 1991
A double-blind, multicenter, parallel-group trial with 0.05% halobetasol propionate ointment versus 0.1% diflucortolone valerate ointment in patients with severe, chronic atopic dermatitis or lichen simplex chronicusN Brunner, S Yawalkar
Journal of the American Academy of Dermatology|December 1, 1991
A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasisH Mensing, G Korsukewitz, S Yawalkar
Journal of the American Academy of Dermatology|December 1, 1991
Halobetasol propionate cream by day and halobetasol propionate ointment at night for the treatment of pediatric patients with chronic, localized plaque psoriasis and atopic dermatitisG Herz, G Blum, S Yawalkar
Journal of the American Academy of Dermatology|December 1, 1991
A double-blind, multicenter comparison of 0.05% halobetasol propionate ointment and 0.05% clobetasol propionate ointment in patients with chronic, localized plaque psoriasisB Goldberg, R Hartdegen, D Presbury, et al.
Journal of the American Academy of Dermatology|December 1, 1991
Dermatopharmacologic investigations of halobetasol propionate in comparison with clobetasol 17-propionateS Yawalkar, I Wiesenberg-Boettcher, J R Gibson, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|June 1, 1992
Modulan grip-aids for leprosy patientsS Yawalkar, A Shah, R Ganapati, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of the American Academy of Dermatology|December 1, 1991
A double-blind, multicenter trial of 0.05% halobetasol propionate ointment and 0.05% clobetasol 17-propionate ointment in the treatment of patients with chronic, localized atopic dermatitis or lichen simplex chronicusB Datz, S Yawalkar
Journal of the American Academy of Dermatology|December 1, 1991
A comparative, multicenter, double blind trial of 0.05% halobetasol propionate ointment and 0.1% betamethasone valerate ointment in the treatment of patients with chronic, localized plaque psoriasisG Blum, S Yawalkar
Journal of the American Academy of Dermatology|December 1, 1991
A double-blind, multicenter, parallel-group trial with 0.05% halobetasol propionate ointment versus 0.1% diflucortolone valerate ointment in patients with severe, chronic atopic dermatitis or lichen simplex chronicusN Brunner, S Yawalkar
Journal of the American Academy of Dermatology|December 1, 1991
A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasisH Mensing, G Korsukewitz, S Yawalkar
Journal of the American Academy of Dermatology|December 1, 1991
Halobetasol propionate cream by day and halobetasol propionate ointment at night for the treatment of pediatric patients with chronic, localized plaque psoriasis and atopic dermatitisG Herz, G Blum, S Yawalkar
Journal of the American Academy of Dermatology|December 1, 1991
A double-blind, multicenter comparison of 0.05% halobetasol propionate ointment and 0.05% clobetasol propionate ointment in patients with chronic, localized plaque psoriasisB Goldberg, R Hartdegen, D Presbury, et al.
Journal of the American Academy of Dermatology|December 1, 1991
Dermatopharmacologic investigations of halobetasol propionate in comparison with clobetasol 17-propionateS Yawalkar, I Wiesenberg-Boettcher, J R Gibson, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|June 1, 1992
Modulan grip-aids for leprosy patientsS Yawalkar, A Shah, R Ganapati, et al.
Pageof 1